PAHO-WHO Statement on adverse events following receiving yellow fever vaccine
|Name:||PAHO-WHO Statement on adverse events following receiving yellow fever vaccine|
This PAHO/WHO statement provides results of the investigation of serious adverse events that occurred in October 2007 following administration of yellow fever vaccine (17DD substrain) manufactured by Bio-Manguinhos, Brazil.
A previous PAHO/WHO statement on the reported events was issued on 2 November 2007 and recommended temporary suspension of specific lots of the vaccine.
|Filetype:||pdf (Mime Type: link)|
|Created On:||09/15/2008 11:48|
|Last updated on:||09/15/2008 11:49|